<?xml version="1.0" encoding="UTF-8"?>
<ref id="B74">
 <label>74.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Zhu</surname>
    <given-names>X</given-names>
   </name>
   <span xml:space="preserve" class="x" xmlns="http://www.w3.org/1999/xhtml">, </span>
   <name name-style="western">
    <surname>Liu</surname>
    <given-names>Q</given-names>
   </name>
   <span xml:space="preserve" class="x" xmlns="http://www.w3.org/1999/xhtml">, </span>
   <name name-style="western">
    <surname>Du</surname>
    <given-names>L</given-names>
   </name>
   <span xml:space="preserve" class="x" xmlns="http://www.w3.org/1999/xhtml">, </span>
   <name name-style="western">
    <surname>Lu</surname>
    <given-names>L</given-names>
   </name>
   <span xml:space="preserve" class="x" xmlns="http://www.w3.org/1999/xhtml">, </span>
   <name name-style="western">
    <surname>Jiang</surname>
    <given-names>S</given-names>
   </name>
  </person-group>
  <article-title>Receptor-binding domain as a target for developing SARS vaccines</article-title>. 
  <source>J. Thorac. Dis.</source>
  <volume>5</volume>, 
  <fpage>S142</fpage>â€“
  <lpage>S148</lpage> (
  <year>2013</year>).
  <pub-id pub-id-type="pmid">23977435</pub-id>
 </mixed-citation>
</ref>
